The Preventive Effect of Oxytocin on Retinopathy in Streptozotocin-Induced Diabetic Rats

Overview

Journal Turk J Ophthalmol

Specialty Ophthalmology

Date 2019 May 6

PMID 31055890

Citations 3

Authors

Cumali Degirmenci

Filiz Afrashi

Oytun Erbas

Huseyin Aktug

Dilek Taskiran

Affiliations

Soon will be listed here.

Abstract

Objectives: The aim of this study was to investigate the impact of intravitreal and intraperitoneal use of oxytocin (OT) on retinopathy in streptozotocin-induced diabetic rats.

Materials And Methods: Twenty-four 6–8-week-old adult male and female Sprague Dawley rats were used in the study. Diabetes was induced in the rats with a single injection of intraperitoneal streptozotocin. Diabetes was verified after 48 hours by measuring blood glucose levels of 260 mg/dl (14.4 mmol/L) or higher in diabetic rats. The rats were divided into 4 groups and treated as follows: intravitreal physiological saline group (0.01 mL saline weekly), intravitreal OT group (10 μU/μL OT weekly), intraperitoneal physiological saline group (1 mL daily), and intraperitoneal OT group (100 IU/kg OT daily). Hamilton syringes fitted with 27-gauge needles were used for intraperitoneal injections while 31-gauge needles were used for intravitreal injection. After 4 weeks of treatment the rats were euthanized to evaluate outer nuclear layer (ONL) thickness, vascular endothelial growth factor (VEGF) immunoexpression, and plasma VEGF levels from blood samples obtained by cardiac puncture.

Results: Morphometric analysis of retinal cross-sections showed that intravitreal and intraperitoneal OT significantly increased ONL thickness compared to physiological saline-treated groups. Also, OT treatment significantly decreased VEGF protein expression compared with the physiological saline groups. Plasma VEGF level was significantly higher in the physiological saline treatment group compared to the OT treatment group.

Conclusion: OT reduces diabetic retinopathy progression, particularly when administered intravitreally. To our knowledge, this is the first attempt to investigate the impact of OT on diabetic retinopathy and may provide a new area for further research.

Citing Articles

Posttranslational modifications of proteins in diseased retina.

Starr C, Gorbatyuk M Front Cell Neurosci. 2023; 17:1150220.

PMID: 37066080 PMC: 10097899. DOI: 10.3389/fncel.2023.1150220.

Neural Functions of Hypothalamic Oxytocin and its Regulation.

Wang P, Wang S, Liu X, Jia S, Wang X, Li T ASN Neuro. 2022; 14:17590914221100706.

PMID: 35593066 PMC: 9125079. DOI: 10.1177/17590914221100706.

Mehdi S, Pusapati S, Khenhrani R, Farooqi M, Sarwar S, Alnasarat A Front Immunol. 2022; 13:864007.

PMID: 35572539 PMC: 9102389. DOI: 10.3389/fimmu.2022.864007.

References

Gimpl G, Fahrenholz F . The oxytocin receptor system: structure, function, and regulation. Physiol Rev. 2001; 81(2):629-83. DOI: 10.1152/physrev.2001.81.2.629. View

Petersson M, Wiberg U, Lundeberg T, Uvnas-Moberg K . Oxytocin decreases carrageenan induced inflammation in rats. Peptides. 2001; 22(9):1479-84. DOI: 10.1016/s0196-9781(01)00469-7. View

Funatsu H, Yamashita H, Ikeda T, Nakanishi Y, Kitano S, Hori S . Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with diabetic macular edema and other retinal disorders. Am J Ophthalmol. 2002; 133(4):537-43. DOI: 10.1016/s0002-9394(02)01323-5. View

Park S, Park J, Park S, Kim K, Chung J, Chun M . Apoptotic death of photoreceptors in the streptozotocin-induced diabetic rat retina. Diabetologia. 2003; 46(9):1260-8. DOI: 10.1007/s00125-003-1177-6. View

Iseri S, Sener G, Saglam B, Gedik N, Ercan F, Yegen B . Oxytocin ameliorates oxidative colonic inflammation by a neutrophil-dependent mechanism. Peptides. 2005; 26(3):483-91. DOI: 10.1016/j.peptides.2004.10.005. View

Brownlee M . The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005; 54(6):1615-25. DOI: 10.2337/diabetes.54.6.1615. View

Matsuoka M, Ogata N, Minamino K, Matsumura M . Expression of pigment epithelium-derived factor and vascular endothelial growth factor in fibrovascular membranes from patients with proliferative diabetic retinopathy. Jpn J Ophthalmol. 2006; 50(2):116-20. DOI: 10.1007/s10384-005-0294-9. View

Kowluru R, Chan P . Oxidative stress and diabetic retinopathy. Exp Diabetes Res. 2007; 2007:43603. PMC: 1880867. DOI: 10.1155/2007/43603. View

Zhang J, Wu Y, Jin Y, Ji F, Sinclair S, Luo Y . Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes. Invest Ophthalmol Vis Sci. 2008; 49(2):732-42. DOI: 10.1167/iovs.07-0721. View

10.

Zong H, Ward M, Stitt A . AGEs, RAGE, and diabetic retinopathy. Curr Diab Rep. 2011; 11(4):244-52. DOI: 10.1007/s11892-011-0198-7. View

11.

Rashed L, Hashem R, Soliman H . Oxytocin inhibits NADPH oxidase and P38 MAPK in cisplatin-induced nephrotoxicity. Biomed Pharmacother. 2011; 65(7):474-80. DOI: 10.1016/j.biopha.2011.07.001. View

12.

Ding J, Wong T . Current epidemiology of diabetic retinopathy and diabetic macular edema. Curr Diab Rep. 2012; 12(4):346-54. DOI: 10.1007/s11892-012-0283-6. View

13.

Erbas O, Ergenoglu A, Akdemir A, Yeniel A, Taskiran D . Comparison of melatonin and oxytocin in the prevention of critical illness polyneuropathy in rats with experimentally induced sepsis. J Surg Res. 2013; 183(1):313-20. DOI: 10.1016/j.jss.2012.11.043. View

14.

Chen M, Curtis T, Stitt A . Advanced glycation end products and diabetic retinopathy. Curr Med Chem. 2013; 20(26):3234-40. DOI: 10.2174/09298673113209990025. View

15.

Kastelan S, Tomic M, Gverovic Antunica A, Salopek Rabatic J, Ljubic S . Inflammation and pharmacological treatment in diabetic retinopathy. Mediators Inflamm. 2013; 2013:213130. PMC: 3830881. DOI: 10.1155/2013/213130. View

16.

Osaadon P, Fagan X, Lifshitz T, Levy J . A review of anti-VEGF agents for proliferative diabetic retinopathy. Eye (Lond). 2014; 28(5):510-20. PMC: 4017101. DOI: 10.1038/eye.2014.13. View

17.

Tarr J, Kaul K, Chopra M, Kohner E, Chibber R . Pathophysiology of diabetic retinopathy. ISRN Ophthalmol. 2014; 2013:343560. PMC: 3914226. DOI: 10.1155/2013/343560. View

18.

Boretsky A, Gupta P, Tirgan N, Liu R, Godley B, Zhang W . Nicotine accelerates diabetes-induced retinal changes. Curr Eye Res. 2014; 40(4):368-77. PMC: 4451833. DOI: 10.3109/02713683.2014.924147. View

19.

Halbach P, Pillers D, York N, Asuma M, Chiu M, Luo W . Oxytocin expression and function in the posterior retina: a novel signaling pathway. Invest Ophthalmol Vis Sci. 2015; 56(2):751-60. PMC: 4554231. DOI: 10.1167/iovs.14-15646. View

20.

Wang X, Yu T, Yan Q, Wang W, Meng N, Li X . AGEs Promote Oxidative Stress and Induce Apoptosis in Retinal Pigmented Epithelium Cells RAGE-dependently. J Mol Neurosci. 2015; 56(2):449-60. DOI: 10.1007/s12031-015-0496-7. View